Opus Genetics, Inc. Contracts Receivable, Claims and Uncertain Amounts, Expected to be Collected in Next Twelve Months
Opus Genetics, Inc. (IRD) had Contracts Receivable, Claims and Uncertain Amounts, Expected to be Collected in Next Twelve Months of $4.67 thousand as of 2012-06-30, per its 10-Q filed 2012-08-08.
Discontinued › Notes
us-gaap:ContractsReceivableClaimsAndUncertainAmountsExpectedToBeCollectedWithinOneYear · last filed 2012-08-08
- 2012-06-30: Contracts Receivable, Claims and Uncertain Amounts, Expected to be Collected in Next Twelve Months $4.67K.
| Period end | Contracts Receivable, Claims and Uncertain Amounts, Expected to be Collected in Next Twelve Months |
|---|---|
| 2012-06-30 | $4.67K 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |